Antibodies

Antibodies

Primary Antibodies

MEK3

C-JUN

B7-1

IRF3

TNF ALPHA

Human

Mouse

Rat

Dog

Monkey

WB

IHC

IF

FC

ELISA

LMNX

10k-ChIP

Mouse

KO Validated Antibodies

Unconjugated

IgG1

IgG2b

IgG2a

Monoclonal

TrueMAB

UltraMAB

Druggable Genome

Protein Kinase

Transcription Factors

Transmembrane

ES Cell Differentiation/IPS

Secreted Protein

MAPK signaling pathway

Pathways in cancer

Toll-like receptor signaling pathway

Wnt signaling pathway

Amyotrophic lateral sclerosis (ALS)

Colorectal cancer

GnRH signaling pathway

Prostate cancer

Cell cycle

Endometrial cancer

Fc epsilon RI signaling pathway

Thyroid cancer

p53 signaling pathway

Basal cell carcinoma

Chronic myeloid leukemia

Bladder cancer

Focal adhesion

Neurotrophin signaling pathway

Small cell lung cancer

Adherens junction

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

ErbB signaling pathway

Glioma

Melanogenesis

Melanoma

Apoptosis

Leukocyte transendothelial migration

Non-small cell lung cancer

Pancreatic cancer

Pathogenic Escherichia coli infection

TGF-beta signaling pathway

Tight junction

Acute myeloid leukemia

DNA replication

Huntington's disease

RNA degradation

Renal cell carcinoma

T cell receptor signaling pathway

Allograft rejection

Antigen processing and presentation

B cell receptor signaling pathway

Epithelial cell signaling in Helicobacter pylori infection

Graft-versus-host disease

Jak-STAT signaling pathway

Primary immunodeficiency

Systemic lupus erythematosus

Type I diabetes mellitus

Autoimmune thyroid disease

Cell adhesion molecules (CAMs)

Neuroactive ligand-receptor interaction

Oocyte meiosis

Progesterone-mediated oocyte maturation

RIG-I-like receptor signaling pathway

Ubiquitin mediated proteolysis

Viral myocarditis

Adipocytokine signaling pathway

Alzheimer's disease

Asthma

Base excision repair

Cytokine-cytokine receptor interaction

Cytosolic DNA-sensing pathway

Dilated cardiomyopathy

Dorso-ventral axis formation

Endocytosis

Hematopoietic cell lineage

Hypertrophic cardiomyopathy (HCM)

Lysine degradation

Maturity onset diabetes of the young

NOD-like receptor signaling pathway

Natural killer cell mediated cytotoxicity

Notch signaling pathway

Type II diabetes mellitus

Carrier-free Antibodies

1